What is Ingevity Corp's earnings per share (EPS)?

Ingevity Corp (NGVT) reported diluted earnings per share of $-4.61 for fiscal year 2025. This represents a 61.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ingevity Corp Financials

NGVT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Ingevity Corp (NGVT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 39/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

100

Ingevity Corp has an operating margin of 35.9%, meaning the company retains $36 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 35.5% the prior year.

Growth

Ingevity Corp's revenue declined 2.7% year-over-year, from $1.2B to $1.2B. This contraction results in a growth score of 29/100.

Leverage

Ingevity Corp has elevated debt relative to equity (D/E of 39.10), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Ingevity Corp's current ratio of 1.33 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Cash Flow

Ingevity Corp converts 23.4% of revenue into free cash flow ($273.5M). This strong cash generation earns a score of 84/100.

Returns

Ingevity Corp generates a -562.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -220.4% the prior year.

Altman Z-Score Grey Zone

2.91

Ingevity Corp scores 2.91, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

6/9

Ingevity Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-1.98x

For every $1 of reported earnings, Ingevity Corp generates $-1.98 in operating cash flow ($331.2M OCF vs -$167.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe

5.3x

Ingevity Corp earns $5.3 in operating income for every $1 of interest expense ($418.7M vs $78.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY-2.7%

5Y CAGR-0.8%

10Y CAGR+2.0%

Ingevity Corp generated $1.2B in revenue in fiscal year 2025. This represents a decrease of 2.7% from the prior year.

EBITDA

$525.1M

YoY-1.7%

5Y CAGR+1.1%

10Y CAGR+10.1%

Ingevity Corp's EBITDA was $525.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.7% from the prior year.

Net Income

-$167.1M

YoY+61.2%

Ingevity Corp reported -$167.1M in net income in fiscal year 2025. This represents an increase of 61.2% from the prior year.

EPS (Diluted)

$-4.61

YoY+61.1%

Ingevity Corp earned $-4.61 per diluted share (EPS) in fiscal year 2025. This represents an increase of 61.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$273.5M

YoY+436.3%

5Y CAGR+0.2%

Ingevity Corp generated $273.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 436.3% from the prior year.

Cash & Debt

$78.1M

YoY+14.9%

5Y CAGR-21.2%

10Y CAGR+9.3%

Ingevity Corp held $78.1M in cash against $1.2B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

35M

YoY-2.4%

5Y CAGR-2.6%

Ingevity Corp had 35M shares outstanding in fiscal year 2025. This represents a decrease of 2.4% from the prior year.

Margins & Returns

Gross Margin

39.5%

YoY+0.8pp

5Y CAGR+1.3pp

10Y CAGR+10.8pp

Ingevity Corp's gross margin was 39.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the prior year.

Operating Margin

35.9%

YoY+0.4pp

5Y CAGR+3.1pp

10Y CAGR+18.5pp

Ingevity Corp's operating margin was 35.9% in fiscal year 2025, reflecting core business profitability. This is up 0.4 percentage points from the prior year.

Net Margin

-14.3%

YoY+21.5pp

5Y CAGR-29.2pp

10Y CAGR-22.6pp

Ingevity Corp's net profit margin was -14.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 21.5 percentage points from the prior year.

Return on Equity

-562.6%

YoY-342.2pp

5Y CAGR-590.9pp

10Y CAGR-578.1pp

Ingevity Corp's ROE was -562.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 342.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$28.4M

YoY+15.9%

5Y CAGR+4.7%

10Y CAGR+5.0%

Ingevity Corp invested $28.4M in research and development in fiscal year 2025. This represents an increase of 15.9% from the prior year.

Share Buybacks

$56.3M

5Y CAGR-8.5%

Ingevity Corp spent $56.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$57.7M

YoY-25.6%

5Y CAGR-6.8%

10Y CAGR-5.4%

Ingevity Corp invested $57.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 25.6% from the prior year.

NGVT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.2B-2.7%	$1.2B-1.3%	$1.2B-27.1%	$1.7B+19.9%	$1.4B+14.4%	$1.2B
Cost of Revenue	$706.1M-4.0%	$735.3M-4.6%	$770.5M-29.8%	$1.1B+25.0%	$878.7M+17.1%	$750.6M
Gross Profit	$461.5M-0.7%	$464.8M+4.4%	$445.0M-21.9%	$570.1M+11.2%	$512.8M+10.2%	$465.5M
R&D Expenses	$28.4M+15.9%	$24.5M-3.5%	$25.4M-16.2%	$30.3M+15.2%	$26.3M+16.4%	$22.6M
SG&A Expenses	$171.2M+8.5%	$157.8M-2.5%	$161.8M-18.6%	$198.8M+10.9%	$179.3M+20.0%	$149.4M
Operating Income	$418.7M-1.7%	$425.9M+0.6%	$423.2M-6.5%	$452.6M+7.2%	$422.2M+6.1%	$397.9M
Interest Expense	$78.3M-19.9%	$97.8M+4.8%	$93.3M+51.0%	$61.8M+19.5%	$51.7M+9.8%	$47.1M
Income Tax	$8.2M+142.9%	-$19.1M-178.9%	$24.2M-58.3%	$58.0M+29.8%	$44.7M-16.8%	$53.7M
Net Income	-$167.1M+61.2%	-$430.3M-7868.5%	-$5.4M-102.6%	$211.6M+79.2%	$118.1M-34.9%	$181.4M
EPS (Diluted)	$-4.61+61.1%	$-11.85-7800.0%	$-0.15-102.7%	$5.50+86.4%	$2.95-32.5%	$4.37

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$185.4M-44.3%	$333.1M-8.8%	$365.1M+28.6%	$284.0M+109.4%	$135.6M-59.4%	$333.8M-14.5%	$390.6M+14.8%	$340.1M
Cost of Revenue	$109.1M-45.2%	$199.2M-12.3%	$227.2M+33.2%	$170.6M+574.3%	$25.3M-87.5%	$202.2M-24.4%	$267.4M+11.2%	$240.4M
Gross Profit	$76.3M-43.0%	$133.9M-2.9%	$137.9M+21.6%	$113.4M+2.8%	$110.3M-16.2%	$131.6M+6.8%	$123.2M+23.6%	$99.7M
R&D Expenses	$5.9M-15.7%	$7.0M-10.3%	$7.8M+1.3%	$7.7M+83.3%	$4.2M-32.3%	$6.2M-15.1%	$7.3M+7.4%	$6.8M
SG&A Expenses	$39.8M-9.8%	$44.1M-0.2%	$44.2M+2.6%	$43.1M+37.7%	$31.3M-17.4%	$37.9M-8.5%	$41.4M-12.3%	$47.2M
Operating Income	N/A	N/A	N/A	N/A	$137.5M+24.8%	$110.2M+8.8%	$101.3M+31.7%	$76.9M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$23.3M-208.9%	$21.4M+463.2%	$3.8M-39.7%	$6.3M-84.7%	$41.2M+533.8%	$6.5M+112.8%	-$50.9M-220.1%	-$15.9M
Net Income	-$84.6M-294.5%	$43.5M+129.7%	-$146.5M-814.6%	$20.5M+23.5%	$16.6M+115.5%	-$107.2M+62.2%	-$283.7M-406.6%	-$56.0M
EPS (Diluted)	N/A	$1.18+129.4%	$-4.02-817.9%	$0.56	N/A	$-2.94+62.4%	$-7.81-407.1%	$-1.54

NGVT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.7B-18.4%	$2.0B-22.9%	$2.6B-4.1%	$2.7B+10.8%	$2.5B+5.8%	$2.3B
Current Assets	$454.2M-7.9%	$493.2M-25.1%	$658.6M-3.6%	$683.3M-5.7%	$724.9M+15.3%	$628.7M
Cash & Equivalents	$78.1M+14.9%	$68.0M-29.1%	$95.9M+25.0%	$76.7M-72.1%	$275.4M+6.9%	$257.7M
Inventory	$186.0M-5.1%	$195.9M-36.6%	$308.8M-7.8%	$335.0M+38.9%	$241.2M+27.6%	$189.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$148.0M
Goodwill	$4.3M-97.5%	$175.2M-66.8%	$527.5M+1.7%	$518.5M+17.3%	$442.0M-0.7%	$445.3M
Total Liabilities	$1.6B-11.3%	$1.8B-8.3%	$2.0B-2.3%	$2.0B+13.5%	$1.8B+6.1%	$1.7B
Current Liabilities	$341.3M+29.2%	$264.1M-27.2%	$362.9M+19.6%	$303.5M+12.9%	$268.9M+20.4%	$223.4M
Long-Term Debt	$1.2B-13.3%	$1.3B-3.1%	$1.4B-6.1%	$1.5B+17.8%	$1.3B-1.4%	$1.3B
Total Equity	$29.7M-84.8%	$195.2M-69.1%	$631.4M-9.6%	$698.3M+3.6%	$673.8M+4.9%	$642.1M
Retained Earnings	$404.9M-29.2%	$572.0M-42.9%	$1.0B-0.5%	$1.0B+26.6%	$796.1M+17.4%	$678.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.7B-10.0%	$1.8B-2.3%	$1.9B-8.7%	$2.1B+1.7%	$2.0B-8.5%	$2.2B-2.8%	$2.3B-11.3%	$2.6B
Current Assets	$454.2M-13.0%	$522.2M-2.6%	$536.0M+1.1%	$530.0M+7.5%	$493.2M-22.6%	$636.8M-7.1%	$685.8M+2.5%	$669.2M
Cash & Equivalents	$78.1M-6.4%	$83.4M+8.5%	$76.9M+7.6%	$71.5M+5.1%	$68.0M-49.8%	$135.5M+26.2%	$107.4M+21.4%	$88.5M
Inventory	$186.0M-4.0%	$193.7M-12.1%	$220.3M-10.2%	$245.4M+25.3%	$195.9M-24.9%	$261.0M-13.6%	$302.0M-7.2%	$325.5M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$4.3M0.0%	$4.3M0.0%	$4.3M-97.6%	$180.7M+3.1%	$175.2M-6.3%	$186.9M+5.6%	$177.0M-66.3%	$525.9M
Total Liabilities	$1.6B-4.4%	$1.7B-3.5%	$1.8B-3.5%	$1.8B-0.3%	$1.8B-8.5%	$2.0B+0.3%	$2.0B-0.4%	$2.0B
Current Liabilities	$341.3M-17.1%	$411.6M+4.7%	$393.1M+48.6%	$264.6M+0.2%	$264.1M-26.8%	$360.8M+0.8%	$357.8M+1.7%	$351.7M
Long-Term Debt	$1.2B+0.3%	$1.2B-6.2%	$1.2B-7.3%	$1.3B-0.5%	$1.3B-4.1%	$1.4B-0.2%	$1.4B-0.5%	$1.4B
Total Equity	$29.7M-78.5%	$138.1M+14.4%	$120.7M-48.6%	$234.6M+20.2%	$195.2M-9.0%	$214.5M-24.7%	$284.8M-49.9%	$568.2M
Retained Earnings	$404.9M-17.3%	$489.5M+9.8%	$446.0M-24.7%	$592.5M+3.6%	$572.0M+3.0%	$555.4M-16.2%	$662.6M-30.0%	$946.3M

NGVT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$331.2M+157.5%	$128.6M-37.3%	$205.1M-34.6%	$313.4M+6.9%	$293.3M-16.8%	$352.4M
Capital Expenditures	$57.7M-25.6%	$77.6M-29.3%	$109.8M-22.9%	$142.5M+37.3%	$103.8M+26.4%	$82.1M
Free Cash Flow	$273.5M+436.3%	$51.0M-46.5%	$95.3M-44.2%	$170.9M-9.8%	$189.5M-29.9%	$270.3M
Investing Cash Flow	-$57.5M+27.7%	-$79.5M-2.8%	-$77.3M+86.0%	-$551.9M-298.2%	-$138.6M-25.3%	-$110.6M
Financing Cash Flow	-$252.2M-259.3%	-$70.2M+29.7%	-$99.9M-307.7%	$48.1M+136.1%	-$133.1M-165.1%	-$50.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$56.3M	$0-100.0%	$92.1M-36.6%	$145.2M+32.7%	$109.4M+24.3%	$88.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$97.1M-25.1%	$129.7M+64.2%	$79.0M+211.0%	$25.4M-60.6%	$64.5M+38.7%	$46.5M+56.6%	$29.7M+345.5%	-$12.1M
Capital Expenditures	$23.6M+98.3%	$11.9M-2.5%	$12.2M+22.0%	$10.0M-59.8%	$24.9M+38.3%	$18.0M-0.6%	$18.1M+9.0%	$16.6M
Free Cash Flow	$73.5M-37.6%	$117.8M+76.3%	$66.8M+333.8%	$15.4M-61.1%	$39.6M+38.9%	$28.5M+145.7%	$11.6M+140.4%	-$28.7M
Investing Cash Flow	-$15.1M+46.3%	-$28.1M-903.6%	-$2.8M+75.7%	-$11.5M+58.9%	-$28.0M-60.9%	-$17.4M+2.2%	-$17.8M-9.2%	-$16.3M
Financing Cash Flow	-$83.4M+12.0%	-$94.8M-50.5%	-$63.0M-472.7%	-$11.0M+88.7%	-$97.6M-1449.2%	-$6.3M-161.2%	$10.3M-56.0%	$23.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$31.1M	N/A	N/A	N/A	$0	$0	$0	$0

NGVT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	39.5%+0.8pp	38.7%+2.1pp	36.6%+2.4pp	34.2%-2.7pp	36.9%-1.4pp	38.3%
Operating Margin	35.9%+0.4pp	35.5%+0.7pp	34.8%+7.7pp	27.1%-3.2pp	30.3%-2.4pp	32.7%
Net Margin	-14.3%+21.5pp	-35.9%-35.4pp	-0.4%-13.1pp	12.7%+4.2pp	8.5%-6.4pp	14.9%
Return on Equity	-562.6%-342.2pp	-220.4%-219.6pp	-0.9%-31.2pp	30.3%+12.8pp	17.5%-10.7pp	28.2%
Return on Assets	-10.1%+11.2pp	-21.3%-21.1pp	-0.2%-7.9pp	7.7%+2.9pp	4.8%-3.0pp	7.8%
Current Ratio	1.33-0.5	1.87+0.1	1.81-0.4	2.25-0.4	2.70-0.1	2.81
Debt-to-Equity	39.10+32.2	6.86+4.7	2.19+0.1	2.11+0.3	1.86-0.1	1.97
FCF Margin	23.4%+19.2pp	4.3%-3.6pp	7.8%-2.4pp	10.2%-3.4pp	13.6%-8.6pp	22.2%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	41.1%+0.9pp	40.2%+2.4pp	37.8%-2.2pp	39.9%-41.4pp	81.3%+41.9pp	39.4%+7.9pp	31.5%+2.2pp	29.3%
Operating Margin	N/A	N/A	N/A	N/A	101.4%+68.4pp	33.0%+7.1pp	25.9%+3.3pp	22.6%
Net Margin	-45.6%-58.7pp	13.1%+53.2pp	-40.1%-47.3pp	7.2%-5.0pp	12.2%+44.4pp	-32.1%+40.5pp	-72.6%-56.2pp	-16.5%
Return on Equity	-284.9%-316.4pp	31.5%+152.9pp	-121.4%-130.1pp	8.7%+0.2pp	8.5%+58.5pp	-50.0%+49.6pp	-99.6%-89.8pp	-9.9%
Return on Assets	-5.1%-7.5pp	2.4%+10.2pp	-7.8%-8.8pp	1.0%+0.2pp	0.8%+5.7pp	-4.9%+7.6pp	-12.5%-10.3pp	-2.2%
Current Ratio	1.33+0.1	1.27-0.1	1.36-0.6	2.00+0.1	1.87+0.1	1.76-0.2	1.92+0.0	1.90
Debt-to-Equity	39.10+30.7	8.39-1.8	10.24+4.6	5.68-1.2	6.86+0.3	6.52+1.6	4.92+2.4	2.48
FCF Margin	39.6%+4.3pp	35.4%+17.1pp	18.3%+12.9pp	5.4%-23.8pp	29.2%+20.7pp	8.5%+5.6pp	3.0%+11.4pp	-8.4%

Similar Companies

$1.8B

$2.2B

$3.2B

$2.1B

$2.5B

Frequently Asked Questions

What is Ingevity Corp's annual revenue?

Ingevity Corp (NGVT) reported $1.2B in total revenue for fiscal year 2025. This represents a -2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ingevity Corp's revenue growing?

Ingevity Corp (NGVT) revenue declined by 2.7% year-over-year, from $1.2B to $1.2B in fiscal year 2025.

Is Ingevity Corp profitable?

No, Ingevity Corp (NGVT) reported a net income of -$167.1M in fiscal year 2025, with a net profit margin of -14.3%.

What is Ingevity Corp's EBITDA?

Ingevity Corp (NGVT) had EBITDA of $525.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Ingevity Corp have?

As of fiscal year 2025, Ingevity Corp (NGVT) had $78.1M in cash and equivalents against $1.2B in long-term debt.

What is Ingevity Corp's gross margin?

Ingevity Corp (NGVT) had a gross margin of 39.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ingevity Corp's operating margin?

Ingevity Corp (NGVT) had an operating margin of 35.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ingevity Corp's net profit margin?

Ingevity Corp (NGVT) had a net profit margin of -14.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ingevity Corp's return on equity (ROE)?

Ingevity Corp (NGVT) has a return on equity of -562.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ingevity Corp's free cash flow?

Ingevity Corp (NGVT) generated $273.5M in free cash flow during fiscal year 2025. This represents a 436.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ingevity Corp's operating cash flow?

Ingevity Corp (NGVT) generated $331.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ingevity Corp's total assets?

Ingevity Corp (NGVT) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ingevity Corp's capital expenditures?

Ingevity Corp (NGVT) invested $57.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Ingevity Corp spend on research and development?

Ingevity Corp (NGVT) invested $28.4M in research and development during fiscal year 2025.

Does Ingevity Corp buy back shares?

Yes, Ingevity Corp (NGVT) spent $56.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Ingevity Corp have outstanding?

Ingevity Corp (NGVT) had 35M shares outstanding as of fiscal year 2025.

What is Ingevity Corp's current ratio?

Ingevity Corp (NGVT) had a current ratio of 1.33 as of fiscal year 2025, which is considered adequate.

What is Ingevity Corp's debt-to-equity ratio?

Ingevity Corp (NGVT) had a debt-to-equity ratio of 39.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ingevity Corp's return on assets (ROA)?

Ingevity Corp (NGVT) had a return on assets of -10.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ingevity Corp's Altman Z-Score?

Ingevity Corp (NGVT) has an Altman Z-Score of 2.91, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ingevity Corp's Piotroski F-Score?

Ingevity Corp (NGVT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ingevity Corp's earnings high quality?

Ingevity Corp (NGVT) has an earnings quality ratio of -1.98x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Ingevity Corp cover its interest payments?

Ingevity Corp (NGVT) has an interest coverage ratio of 5.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Ingevity Corp?

Ingevity Corp (NGVT) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.